Thymmune
Cambridge, US · 2 known investors
Thymmune Therapeutics develops a machine learning-driven thymic cell engineering platform that mass-produces iPSC-derived thymic cells to restore immune function affected by aging and disease. The company is building a pipeline of off-the-shelf cell therapies for immunodeficiencies, transplant-related, and autoimmune disorders.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Thymmune do?
- Thymmune Therapeutics develops a machine learning-driven thymic cell engineering platform that mass-produces iPSC-derived thymic cells to restore immune function affected by aging and disease. The company is building a pipeline of off-the-shelf cell therapies for immunodeficiencies, transplant-related, and autoimmune disorders.
- Who founded Thymmune?
- Thymmune was founded by Stan Wang, Bing Lim.
- Who are Thymmune's investors?
- Thymmune's investors include Pillar VC, NYBC Ventures.
- Where is Thymmune headquartered?
- Thymmune is headquartered in Cambridge, US.